Johnson & Johnson said it’s delaying the rollout of its Covid-19 vaccine in Europe after U.S. regulators paused immunizations with the shot pending a review of rare blood clots.
Read More
J&J Delays Covid-19 Vaccine in Europe After Rare Clots
Comments Off on J&J Delays Covid-19 Vaccine in Europe After Rare Clots